platinum has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Deguchi, K; Miyamoto, Y; Ohta, Y; Takamiya, M; Yamashita, T | 1 |
1 other study(ies) available for platinum and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.
Topics: Animals; Brain Infarction; Collagen Type IV; Disease Models, Animal; Drug Administration Schedule; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Matrix Metalloproteinase 9; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Movement Disorders; Phenanthridines; Platinum; Reactive Oxygen Species; Regional Blood Flow; Reperfusion; Spectroscopy, Near-Infrared; Superoxides; Time Factors; Tissue Plasminogen Activator | 2012 |